Precisely calibrated small microspheres

  • Sized for tumor penetration at 40 μm, 75 μm, and 100 μm
  • ≥95% of Oncozene Microspheres are within the specified size range[1]

Strength in numbers to deliver more microspheres

  • Greater number of small microspheres facilitates homogenous tumor coverage[2-4]
  • Single unit syringes are available in 2 ml or 3 ml options to deliver even more microspheres

Indicated for the embolization of

  • Arteriovenous malformations
  • Hypervascular tumors including hepatoma This device is not intended for neurovascular use.

Resources

We'll help you get connected

Contact Varian's Interventional Oncology Customer support team

+1 877-467-2009 or vis.support@varian.com.

  1. Date on file. Varian Medical Systems, Inc. 2020.
  2. Delicque, J., et al., Liver chemoembolization of hepatocellular carcinoma using TANDEM® microspheres. Future Oncol, 2018. 14(26): p. 2761-2772.
  3. Tanaka, T., et al., Pharmacokinetics and antitumor efficacy of chemoembolization using 40 micron irinotecan-loaded microspheres in a rabbit liver tumor model. J Vasc Interv Radiol, 2014. 25(7): p. 1037-1044 e2.
  4. She, H.L., et al., In Vivo Proof of Superselective Transarterial Chemoembolization with 40-µm Drug-Eluting Beads in a Patient with Hepatocellular Carcinoma. Cardiovasc Intervent Radiol, 2016. 39(1): p. 137-40.
  5. Blümmel, J., et al., Drug-eluting Beads in the Treatment of Hepatocellular Carcinoma and Colorectal Cancer Metastases to the Liver. European Oncology and Haematology, 2012. 8: p.162-166.